US Tariff Threat Unlikely To Hurt Indian Pharma Immediately; Consolidation Likely, Says Ind-Ra
Moneylife Digital Team
29 July 2026
Proposed tariffs on imported generic pharmaceuticals by US are unlikely to have any immediate negative credit impact on Indian pharmaceuticals companies,…